Predicting the functional impact of protein mutations: application to cancer genomics
By B. Reva, Yevgeniy Antipin, Christopher Sander. 2011
1,977 citations recorded by the source corpus.
As large-scale re-sequencing of genomes reveals many protein mutations, especially in human cancer tissues, prediction of their likely functional impact becomes important practical goal. Here, we introduce a new functional impact score (FIS) for amino acid residue changes using evolutionary conservation patterns. The information in these patterns is derived from aligned families and sub-families of sequence homologs within and between species using combinatorial entropy formalism. The score performs well on a large set of human protein mutations in separating disease-associated variants (∼19 200), assumed to be strongly functional, from common polymorphisms (∼35 600), assumed to be weakly functional (area under the receiver operating characteristic curve of ∼0.86). In cancer, using recurrence, multiplicity and annotation for ∼10 000 mutations in the COSMIC database, the method does well in assigning higher scores to more likely functional mutations (‘drivers’). To guide experimental prioritization, we report a list of about 1000 top human cancer genes frequently mutated in one or more cancer types ranked by likely functional impact; and, an additional 1000 candidate cancer genes with rare but likely functional mutations. In addition, we estimate that at least 5% of cancer-relevant mutations involve switch of function, rather than simply loss or gain of function.
Subfields: Cancer Research, Genetics, Molecular Biology, Computational Biology & Bioinformatics, Medical & Health AI
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Cancer Research
- Eric Boerwinkle
- David N. Cooper
- Peter D. Stenson
- Xiaoming Liu
- Nouf S. Al-Numair
- Andrew C. R. Martin
- Daniel C. Koboldt
- Xueqiu Jian
In Genetics
- B. Feng
- Eric Boerwinkle
- Xiaoming Liu
- David N. Cooper
- Yana Bromberg
- Maximilian Hecht
- Xueqiu Jian
- Burkhard Rost
In Molecular Biology
- Burkhard Rost
- Yang Zhang
- Nick V. Grishin
- Christopher Sander
- B. Feng
- Eric Boerwinkle
- Yana Bromberg
- Martin Weigt
In Computational Biology & Bioinformatics
- Burkhard Rost
- Debora Marks
- Christopher Sander
- Martin Weigt
- Rémi Monasson
- Simona Cocco
- Matteo Figliuzzi
- Nick V. Grishin
In Medical & Health AI
- Eric Boerwinkle
- Xiaoming Liu
- Nouf S. Al-Numair
- Andrew C. R. Martin
- Xueqiu Jian
- David N. Cooper
- Peter D. Stenson
- Hannah Carter
Citations in the corpus
- CADD: predicting the deleteriousness of variants throughout the human genome (2018, methodology): “FATHMM (4), LRT(5), MutationAssessor (6), MutationTaster (7), Polyphen2, PROVEAN (8), REVEL, SIFT, SiPhy(9), VEST (10)) were annotated via dbNSFP.”
- Coevolutionary Landscape Inference and the Context-Dependence of Mutations in Beta-Lactamase TEM-1 (2015, background): “[6] Boris Reva, Yevgeniy Antipin, and Chris Sander.”
- Better prediction of functional effects for sequence variants (2015, neutral): “Some methods focus exclusively on the human genome [12,13] and some aspire to identify disease-causing variants [14-16].”
- Identifying Mendelian disease genes with the Variant Effect Scoring Tool (2013, methodology): “The methods fall broadly into two categories, those that score mutations on the basis of biological principles (SIFT [4], MutationAssessor [5], MAPP [6], PANTHER [7], among others), and methods that use existing knowledge about the functional effects of mutations in the form a training set for super”
- dbNSFP v3.0: A One-Stop Database of Functional Predictions and Annotations for Human Non-synonymous and Splice Site SNVs (2016, methodology): “It added two functional prediction scores, MutationAssessor [Reva et al., 2011] and FATHMM [Shihab et al., 2013]; two conservation scores, GERP++ [Davydov et al., 2010] and SiPhy C© 2015 WILEY PERIODICALS, INC. [Garber et al., 2009; Lindblad-Toh et al., 2011]; and allele frequencies from the 1000…”
- Genomic and Molecular Landscape of DNA Damage Repair Deficiency across The Cancer Genome Atlas (2018, neutral): “, 2014), Mutation Assessor (Reva et al., 2011), LR and LRT (Chun and Fay, 2009).”
- dbNSFP v2.0: A Database of Human Non-synonymous SNVs and Their Functional Predictions and Annotations (2013, methodology): “MutationAssessor provides four types of predictions (to be functional): high, medium, low and neutral.”
- The Evaluation of Tools Used to Predict the Impact of Missense Variants Is Hindered by Two Types of Circularity (2015, methodology): “Second, while MT2, PP2, and MASS outperform CADD and SIFT on benchmarks that includesomeoftheirtrainingdata( HumVar , ExoVar ),thisisnotthe case on the independent VariBenchSelected and predictSNPSelected datasets.”
- Comprehensive Characterization of Cancer Driver Genes and Mutations (2018, methodology): “…level (SIFT [Ng and Henikoff, 2002], PolyPhen2 [Adzhubei et al., 2013], VEST (version 3 scores) [Carter et al., 2013] and MutationAssessor [Reva et al., 2011]), four tools specifically designed to distinguish between driver and passenger somatic mutations (CHASM [Wong et al., 2011],…”
- Protein design and variant prediction using autoregressive generative models (2021, methodology): “However, these state-of-art methods and established methods 35 – 38 rely on sequence families and alignments, and alignment-based methods are inherently unsuitable for the statistical description of the variable length, hypermutated complementarity determining regions (CDRs) of antibody sequences,…”
- The SAAP pipeline and database: tools to analyze the impact and predict the pathogenicity of mutations (2013, methodology): “have a deleterious effect on phenotype [4-15].”
- PERCH: a unified framework for disease gene prioritization (2017, background): “2010), Mutation Assessor (Reva et al. 2011), PhyloP (Pollard et al.”
- Comparison and integration of deleteriousness prediction methods for nonsynonymous SNVs in whole exome sequencing studies. (2015, methodology): “2, released in Feb, 2013) (15), SIFT (Human_db_37_ensembl_63, released inAugust, 2011) (16), MutationTaster (data retrieved in 2013) (8),MutationAssessor (release 2) (2), FATHMM (v2.”